{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:25:44Z","timestamp":1790051144033,"version":"4.0.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T00:00:00Z","timestamp":1322870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00702-011-0741-3","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T14:52:14Z","timestamp":1322923934000},"page":"245-251","source":"Crossref","is-referenced-by-count":86,"title":["The role of the kynurenine metabolism in major depression"],"prefix":"10.1007","volume":"119","author":[{"given":"Aye-Mu","family":"Myint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,3]]},"reference":[{"key":"741_CR1","unstructured":"Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H et al (2004) Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 21\u201327"},{"key":"741_CR2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.mp.4000436","volume":"4","author":"H Anisman","year":"1999","unstructured":"Anisman H, Ravindran AV, Griffiths J, Merali Z (1999) Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4:182\u2013188","journal-title":"Mol Psychiatry"},{"key":"741_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1079\/BJN19890150","volume":"61","author":"DA Bender","year":"1989","unstructured":"Bender DA (1989) Effects of a dietary excess of leucine and of the addition of leucine and 2-oxo-isocaproate on the metabolism of tryptophan and niacin in isolated rat liver cells. Br J Nutr 61:629\u2013640","journal-title":"Br J Nutr"},{"key":"741_CR4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/bst0130441","volume":"13","author":"DA Bender","year":"1985","unstructured":"Bender DA, McCreanor GM (1985) Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism. Biochem Soc Trans 13:441\u2013443","journal-title":"Biochem Soc Trans"},{"key":"741_CR5","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1002\/jnr.21751","volume":"86","author":"O Campuzano","year":"2008","unstructured":"Campuzano O, Castillo-Ruiz MM, Acarin L, Castellano B, Gonzalez B (2008) Distinct pattern of microglial response, cyclooxygenase-2, and inducible nitric oxide synthase expression in the aged rat brain after excitotoxic damage. J Neurosci Res 86:3170\u20133183","journal-title":"J Neurosci Res"},{"key":"741_CR6","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.4049\/jimmunol.139.7.2414","volume":"139","author":"JM Carlin","year":"1987","unstructured":"Carlin JM, Borden EC, Sondel PM, Byrne GI (1987) Biologic-response-modifier-induced indoleamine 2, 3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J Immunol 139:2414\u20132418","journal-title":"J Immunol"},{"key":"741_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-2005-7104","volume":"7","author":"S Chen","year":"2005","unstructured":"Chen S, Averett NT, Manelli A, Ladu MJ, May W, Ard MD (2005) Isoform-specific effects of apolipoprotein E on secretion of inflammatory mediators in adult rat microglia. J Alzheimers Dis 7:25\u201335","journal-title":"J Alzheimers Dis"},{"key":"741_CR8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(01)00418-0","volume":"120","author":"A Chiarugi","year":"2001","unstructured":"Chiarugi A, Calvani M, Meli E, Traggiai E, Moroni F (2001) Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J Neuroimmunol 120:190\u2013198","journal-title":"J Neuroimmunol"},{"key":"741_CR9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0024-3205(97)00990-9","volume":"62","author":"TJ Connor","year":"1998","unstructured":"Connor TJ, Leonard BE (1998) Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62:583\u2013606","journal-title":"Life Sci"},{"key":"741_CR10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2011.01.011","volume":"42","author":"C Depboylu","year":"2011","unstructured":"Depboylu C, Weihe E, Eiden LE (2011) COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection. Neurobiol Dis 42:108\u2013115","journal-title":"Neurobiol Dis"},{"key":"741_CR11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0278-5846(88)90019-X","volume":"12","author":"DL Evans","year":"1988","unstructured":"Evans DL, Pedersen CA, Folds JD (1988) Major depression and immunity: preliminary evidence of decreased natural killer cell populations. Prog Neuropsychopharmacol Biol Psychiatry 12:739\u2013748","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"741_CR12","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/clinchem\/39.11.2337","volume":"39","author":"N Eynard","year":"1993","unstructured":"Eynard N, Flachaire E, Lestra C, Broyer M, Zaidan R, Claustrat B et al (1993) Platelet serotonin content and free and total plasma tryptophan in healthy volunteers during 24 hours. Clin Chem 39:2337\u20132340","journal-title":"Clin Chem"},{"key":"741_CR13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0026-0495(77)90057-9","volume":"26","author":"JD Fernstrom","year":"1977","unstructured":"Fernstrom JD (1977) Effects on the diet on brain neurotransmitters. Metabolism 26:207\u2013223","journal-title":"Metabolism"},{"key":"741_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pnpbp.2009.09.015","volume":"34","author":"V Gabbay","year":"2010","unstructured":"Gabbay V, Liebes L, Katz Y, Liu S, Mendoza S, Babb JS et al (2010) The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry 34:37\u201344","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"741_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00964611","volume":"5","author":"EM Gal","year":"1980","unstructured":"Gal EM, Sherman AD (1980) l-Kynurenine: its synthesis and possible regulatory function in brain. Neurochem Res 5:223\u2013239","journal-title":"Neurochem Res"},{"key":"741_CR16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1046\/j.1471-4159.1998.70041759.x","volume":"70","author":"RS Grant","year":"1998","unstructured":"Grant RS, Kapoor V (1998) Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. J Neurochem 70:1759\u20131763","journal-title":"J Neurochem"},{"key":"741_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1179\/135100000101535357","volume":"5","author":"RS Grant","year":"2000","unstructured":"Grant RS, Naif H, Espinosa M, Kapoor V (2000) IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress. Redox Rep 5:101\u2013104","journal-title":"Redox Rep"},{"key":"741_CR18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1179\/135100000101535375","volume":"5","author":"GJ Guillemin","year":"2000","unstructured":"Guillemin GJ, Smith DG, Kerr SJ, Smythe GA, Kapoor V, Armati PJ et al (2000) Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis. Redox Rep 5:108\u2013111","journal-title":"Redox Rep"},{"key":"741_CR19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","volume":"78","author":"GJ Guillemin","year":"2001","unstructured":"Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ et al (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 78:842\u2013853","journal-title":"J Neurochem"},{"key":"741_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","volume":"49","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ, Smythe G, Takikawa O, Brew BJ (2005) Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49:15\u201323","journal-title":"Glia"},{"key":"741_CR21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M et al (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115:1249\u20131273","journal-title":"Brain"},{"key":"741_CR22","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/brain\/116.6.1425","volume":"116","author":"MP Heyes","year":"1993","unstructured":"Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from l-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116:1425\u20131450","journal-title":"Brain"},{"key":"741_CR23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3200595","volume":"320","author":"MP Heyes","year":"1996","unstructured":"Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP (1996) Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 320:595\u2013597","journal-title":"Biochem J"},{"key":"741_CR24","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21:7463\u20137473","journal-title":"J Neurosci"},{"key":"741_CR25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1440-1819.2000.00754.x","volume":"54","author":"S Hosoda","year":"2000","unstructured":"Hosoda S, Takimura H, Shibayama M, Kanamura H, Ikeda K, Kumada H (2000) Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry Clin Neurosci 54:565\u2013572","journal-title":"Psychiatry Clin Neurosci"},{"key":"741_CR26","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/0024-3205(87)90531-5","volume":"41","author":"M Irwin","year":"1987","unstructured":"Irwin M, Smith TL, Gillin JC (1987) Low natural killer cytotoxicity in major depression. Life Sci 41:2127\u20132133","journal-title":"Life Sci"},{"key":"741_CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2005.03.012","volume":"87","author":"F Kaestner","year":"2005","unstructured":"Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G et al (2005) Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 87:305\u2013311","journal-title":"J Affect Disord"},{"key":"741_CR28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0306-4522(87)90066-2","volume":"23","author":"JP Kim","year":"1987","unstructured":"Kim JP, Choi DW (1987) Quinolinate neurotoxicity in cortical cell culture. Neuroscience 23:423\u2013432","journal-title":"Neuroscience"},{"key":"741_CR29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","volume":"7","author":"YK Kim","year":"2002","unstructured":"Kim YK, Suh IB, Kim H, Han CS, Lim CS, Choi SH et al (2002) The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry 7:1107\u20131114","journal-title":"Mol Psychiatry"},{"key":"741_CR30","first-page":"462","volume":"32","author":"WE Knox","year":"1951","unstructured":"Knox WE (1951) Two mechanisms which increase in vivo the liver tryptophan peroxidase activity: specific enzyme adaptation and stimulation of the pituitary adrenal system. Br J Exp Pathol 32:462\u2013469","journal-title":"Br J Exp Pathol"},{"key":"741_CR31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370\u2013379","journal-title":"Neuropsychopharmacology"},{"key":"741_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(69)91140-4","volume":"1","author":"IP Lapin","year":"1969","unstructured":"Lapin IP, Oxenkrug GF (1969) Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 1:132\u2013136","journal-title":"Lancet"},{"key":"741_CR33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ajcn\/24.6.659","volume":"24","author":"JE Leklem","year":"1971","unstructured":"Leklem JE (1971) Quantitative aspects of tryptophan metabolism in humans and other species: a review. Am J Clin Nutr 24:659\u2013672","journal-title":"Am J Clin Nutr"},{"key":"741_CR34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0006-3223(94)90652-1","volume":"36","author":"M Maes","year":"1994","unstructured":"Maes M (1994) Cytokines in major depression. Biol Psychiatry 36:498\u2013499 (letter; comment)","journal-title":"Biol Psychiatry"},{"key":"741_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S0033291700032712","volume":"22","author":"M Maes","year":"1992","unstructured":"Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C et al (1992a) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22:45\u201353","journal-title":"Psychol Med"},{"key":"741_CR36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0447.1992.tb03292.x","volume":"86","author":"M Maes","year":"1992","unstructured":"Maes M, Stevens W, DeClerck L, Bridts C, Peeters D, Schotte C et al (1992b) Immune disorders in depression: higher T helper\/T suppressor-cytotoxic cell ratio. Acta Psychiatr Scand 86:423\u2013431","journal-title":"Acta Psychiatr Scand"},{"key":"741_CR37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(98)00088-8","volume":"20","author":"M Maes","year":"1999","unstructured":"Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, de Jongh R et al (1999) Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20:370\u2013379","journal-title":"Neuropsychopharmacology"},{"key":"741_CR38","first-page":"293","volume":"11","author":"A Mangoni","year":"1974","unstructured":"Mangoni A (1974) The \u201ckynurenine shunt\u201d and depression. Adv Biochem Psychopharmacol 11:293\u2013298","journal-title":"Adv Biochem Psychopharmacol"},{"key":"741_CR39","volume-title":"Updated projection of global mortality and burden of disease, 2002\u20132030: data sources, methods and results","author":"C Mathers","year":"2005","unstructured":"Mathers C, Loncar D (2005) Updated projection of global mortality and burden of disease, 2002\u20132030: data sources, methods and results. WHO, Geneva"},{"key":"741_CR40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0167-5699(99)01520-0","volume":"20","author":"AL Mellor","year":"1999","unstructured":"Mellor AL, Munn DH (1999) Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 20:469\u2013473","journal-title":"Immunol Today"},{"key":"741_CR41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0924-977X(01)00081-5","volume":"11","author":"O Mikova","year":"2001","unstructured":"Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001) Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11:203\u2013208","journal-title":"Eur Neuropsychopharmacol"},{"key":"741_CR42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nbd.2003.12.015","volume":"15","author":"CL Miller","year":"2004","unstructured":"Miller CL, Llenos IC, Dulay JR, Barillo MM, Yolken RH, Weis S (2004) Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis 15:618\u2013629","journal-title":"Neurobiol Dis"},{"key":"741_CR43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","volume":"81","author":"JR Moffett","year":"2003","unstructured":"Moffett JR, Namboodiri MA (2003) Tryptophan and the immune response. Immunol Cell Biol 81:247\u2013265","journal-title":"Immunol Cell Biol"},{"key":"741_CR44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s004410051145","volume":"293","author":"JR Moffett","year":"1998","unstructured":"Moffett JR, Blinder KL, Venkateshan CN, Namboodiri MA (1998) Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs. Cell Tissue Res 293:525\u2013534","journal-title":"Cell Tissue Res"},{"key":"741_CR45","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N M\u00fcller","year":"2006","unstructured":"M\u00fcller N, Schwarz MJ, Dehning S, Douhet A, Cerovecki A, Goldstein-M\u00fcller B et al (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11:680\u2013684","journal-title":"Mol Psychiatry"},{"key":"741_CR46","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood.V83.5.1408.1408","volume":"83","author":"T Musso","year":"1994","unstructured":"Musso T, Gusella GL, Brooks A, Longo DL, Varesio L (1994) Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood 83:1408\u20131411","journal-title":"Blood"},{"key":"741_CR47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","volume":"61","author":"AM Myint","year":"2003","unstructured":"Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61:519\u2013525","journal-title":"Med Hypotheses"},{"key":"741_CR48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2005.07.008","volume":"88","author":"AM Myint","year":"2005","unstructured":"Myint AM, Leonard BE, Steinbusch HW, Kim YK (2005) Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 88:167\u2013173","journal-title":"J Affect Disord"},{"key":"741_CR49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","volume":"98","author":"AM Myint","year":"2007","unstructured":"Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, Leonard B (2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98:143\u2013151","journal-title":"J Affect Disord"},{"key":"741_CR50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","volume":"70","author":"S Okuda","year":"1998","unstructured":"Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70:299\u2013307","journal-title":"J Neurochem"},{"key":"741_CR51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","volume":"247","author":"MN Perkins","year":"1982","unstructured":"Perkins MN, Stone TW (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247:184\u2013187","journal-title":"Brain Res"},{"key":"741_CR52","first-page":"128","volume":"63","author":"H Pertz","year":"1988","unstructured":"Pertz H, Back W (1988) Synthesis and resolution of chiral ring-opened serotonin analogs of the 5-hydroxykynuramine type. Pharm Acta Helv 63:128\u2013131","journal-title":"Pharm Acta Helv"},{"key":"741_CR53","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1038\/npp.2011.127","volume":"36","author":"A Pocivavsek","year":"2011","unstructured":"Pocivavsek A, Wu HQ, Potter MC, Elmer GI, Pellicciari R, Schwarcz R (2011) Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology 36:2357\u20132367","journal-title":"Neuropsychopharmacology"},{"key":"741_CR54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G et al (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15:393\u2013403","journal-title":"Mol Psychiatry"},{"key":"741_CR55","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","volume":"45","author":"G Rajkowska","year":"1999","unstructured":"Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY et al (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45:1085\u20131098","journal-title":"Biol Psychiatry"},{"key":"741_CR56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/bj2290499","volume":"229","author":"M Salter","year":"1985","unstructured":"Salter M, Pogson CI (1985) The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes. Biochem J 229:499\u2013504","journal-title":"Biochem J"},{"key":"741_CR57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","volume":"29","author":"OJ Schiepers","year":"2005","unstructured":"Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201\u2013217","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"741_CR58","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","volume":"219","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz R, Whetsell WO Jr, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316\u2013318","journal-title":"Science"},{"key":"741_CR59","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1749-6632.1995.tb32372.x","volume":"762","author":"A Sluzewska","year":"1995","unstructured":"Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 762:474\u2013476","journal-title":"Ann N Y Acad Sci"},{"key":"741_CR60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","volume":"64","author":"A Sluzewska","year":"1996","unstructured":"Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M et al (1996) Indicators of immune activation in major depression. Psychiatry Res 64:161\u2013167","journal-title":"Psychiatry Res"},{"key":"741_CR61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298\u2013306","journal-title":"Med Hypotheses"},{"key":"741_CR62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","volume":"42","author":"J Steiner","year":"2008","unstructured":"Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C et al (2008) Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42:151\u2013157","journal-title":"J Psychiatr Res"},{"key":"741_CR63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/appi.ajp.162.1.175","volume":"162","author":"AJ Thomas","year":"2005","unstructured":"Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O\u2019Brien JT (2005) Increase in interleukin-1beta in late-life depression. Am J Psychiatry 162:175\u2013177","journal-title":"Am J Psychiatry"},{"key":"741_CR64","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj1890393","volume":"189","author":"Y Watanabe","year":"1980","unstructured":"Watanabe Y, Fujiwara M, Yoshida R, Hayaishi O (1980) Stereospecificity of hepatic l-tryptophan 2,3-dioxygenase. Biochem J 189:393\u2013405","journal-title":"Biochem J"},{"key":"741_CR65","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","volume":"10","author":"MC Wichers","year":"2005","unstructured":"Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M (2005) IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 10:538\u2013544","journal-title":"Mol Psychiatry"},{"key":"741_CR66","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1073\/pnas.83.17.6622","volume":"83","author":"H Yasui","year":"1986","unstructured":"Yasui H, Takai K, Yoshida R, Hayaishi O (1986) Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. Proc Natl Acad Sci USA 83:6622\u20136626","journal-title":"Proc Natl Acad Sci USA"},{"key":"741_CR67","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1471-4159.1977.tb10664.x","volume":"28","author":"A Yuwiler","year":"1977","unstructured":"Yuwiler A, Oldendorf WH, Geller E, Braun L (1977) Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J Neurochem 28:1015\u20131023","journal-title":"J Neurochem"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0741-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-011-0741-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0741-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T11:33:29Z","timestamp":1686483209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0741-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,3]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0741-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,3]]}}}